# POTASSIUM CITRATE

NDC: 16571-865
Generic name: potassium citrate
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20241215

FDA application: ANDA077440

## Active ingredients

- POTASSIUM CITRATE: 1080 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16571-865"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16571-865
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=164d9d05-fbb1-4d99-8ba3-ff9c172aa8ca